Inhibitory effects of resistant starch (RS3) as a carrier for stachyose on dextran sulfate sodium-induced ulcerative colitis in C57BL/6 mice

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1312-1316

  Yu, Qian ^a,b   Zhao, Xin ^b,c   Jia Le, Song ^c   Zhu, Kai ^b   Sun, Peng ^b   Gui Jie, Li ^b   Wang, Rui ^b   Jian Quan, Kan ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF EDUCATION   (China)

^c Pusan National University   (South Korea)

Author keywords

C57BL 6 mice; Cytokine; Resistant starch; Stachyose

Indexed keywords

INTERLEUKIN 6; POLYSACCHARIDE; STACHYOSE; STARCH; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; MOUSE; NECROSIS; NONHUMAN; ULCERATIVE COLITIS;

EID: 84884734996     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1280     Document Type: Article

References (26)

1. No authors listed: Report of a Joint FAO/WHO Expert Consultation: Carbohydrates in human nutrition. FAO Food Nutr Pap 66: 1-140, 1998.
2. Englyst HN, Kingman SM and Cummings JH: Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr 46 (Suppl 2): S33-S50, 1992.
3. Baghurst PA, Baghurst KI and Record SJ: Dietary fiber, non-starch polysaccharides and resistant starch - a review. Food Australia 48 (Suppl): S1-S36, 1996.
4. Yin J, Yang G, Wang S and Chen Y: Purification and determination of stachyose in Chinese artichoke Stachys Sieboldii Miq.) by high-performance liquid chromatography with evaporative light scattering detection. Talanta 70: 208-212, 2006.
5. Liying Z, Li D, Qiao S, Johnson EW, Li B, Thacker PA and Han IK: Effects of stachyose on performance, diarrhoea incidence and intestinal bacteria in weanling pigs. Arch Tierernahr 57: 1-10, 2003.
6. Macfarlane GT and Cummings JH: Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? West J Med 171: 187-191, 1999.
7. Xu Q, Chao YL and Wan QB: Health benefit application of functional oligosaccharides. Carbohydrate Polymers 77: 435-441, 2009.
8. Jian R, Besterman HS, Sarson DL, et al: Colonic inhibition of gastric secretion in man. Dig Dis Sci 26: 195-201, 1981.
9. Seo GS and Choi SC: Pathophysiology of ulcerative colitis - relationship with genetics and immunity. Korea J Med 76: 643-648, 2009 (In Korean).
10. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al; European Crohn's and Colitis Organisation: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55 (Suppl 1): 1-l5, 2006.
11. Ramadori G and Armbrust T: Cytokines in the liver. Eur J Gastroenterol Hepatol 13: 777-784, 2001.
12. McCurry KR, Campbell DA Jr, Scales WE, Warren JS and Remick DG: Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 55: 49-54, 1993.
13. Ming WJ, Bersani L and Mantovani A: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 138: 1469-1472, 1987.
14. Fayyaz M and Lackner JM: Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag 4: 41-48, 2008.
15. Melgar S, Karlsson L, Rehnström E, Karlsson A, Utkovic H, Jansson L and Michaëlsson E: Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int immunopharmacol 8: 836-844, 2008.
16. Ogawa A, Andoh A, Araki Y, Bamba T and Fujiyama Y: Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110: 55-62, 2004.
17. Soriano A, Salas A, Salas A, Sans M, Gironella M, Elena M, Anderson DC, Piqué JM and Panés J: VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest 80: 1541-1551, 2000.
18. Ferguson-Smith AC, Chen YF, Newman MS, May LT, Sehgal PB and Ruddle FH: Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics 2: 203-208, 1988.
19. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M and Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176: 439-444, 1997.
20. Gosselin D and Rivest S: Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun 21: 281-289, 2007.
21. Wan GS, Zhao ZZ, Qian YL, Xie ZH, Wang ZH and Zhu JJ: Changes in serum levels of SOCS-3, IL-6 and TNF-α and their correlation in patients with ulcerative colitis. World Chinese J Digestol 19: 3370-3373, 2011 (In Chinese).
22. Barondeau DP, Kassmann CJ, Bruns CK, Tainer JA and Getzoff ED: Nickel superoxide dismutase structure and mechanism. Biochemistry 43: 8038-8047, 2004.
23. Gaze DC: The role of existing and novel cardiac biomarkers for cardioprotection. Curr Opin Investig Drugs 8: 711-717, 2007.
24. Alscher RG, Erturk N and Heath LS: Role of superoxide dismutases (SODs) in controlling oxidative stress in plants. J Exp Bot 53: 1331-1341, 2002.
25. Topping DL and Clifton PM: Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81: 1031-1064, 2001.
26. Berggren AM, Bjorck IM, Nyman EM and Eggum BO: Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates. J Sci Food Agri 63: 397-406, 1993.